Shift in disparities in Hepatitis C treatment from interferon to DAA era: A population ‐based cohort study

In conclusion, there is a shift in prescription of new HCV treatments to previously excluded groups (e.g., HIV‐co‐infected), though gaps remain for the socioeconomically marginalized populations.
This article is protected by copyright. All rights reserved.

Source: Journal of Viral Hepatitis - January 28, 2017 Category: Infectious Diseases Authors: Naveed Z. Janjua, Nazrul Islam, Jason Wong, Eric M. Yoshida, Alnoor Ramji, Hasina Samji, Zahid A. Butt, Mei Chong, Darrel Cook, Maria Alvarez, Maryam Darvishian, Mark Tyndall, Mel Krajden Tags: Original Paper Source Type: research